Laura Caba is the President and Co-founder of Vesica Health, a multi-omics liquid biopsy company, committed to transforming the early detection of bladder cancer with a cutting-edge urine-based assay. With over 20 years of experience in clinical trials, medical education, and strategic leadership, Laura is a recognized expert in urology. As the former Vice President of Medical Affairs at MDxHealth, Laura was pivotal in advancing urology-focused diagnostic tests and guiding clinical trials in the U.S. and EU. Her leadership was instrumental in shaping the strategic direction of the company’s medical education and engagement with academic leaders. Her unique blend of clinical expertise and business acumen, supported by a Master of Public Health and a Bachelor of Business Administration in Marketing, drives her ability to scale innovative healthcare solutions.
In addition to her professional roles, Laura serves on the Board of IVUMed (International Volunteers in Urology) and is a member of the Society of Women in Urology (SWIU) and the International Bladder Cancer Network (IBCN).